Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Curetis N.V.. (10/4/16). "Press Release: Curetis to Present at Several Investor and Scientific Conferences in the Fourth Quarter 2016". Amsterdam & Holzgerlingen.

Organisations Organisation Curetis N.V.
  Group Curetis (Group)
  Organisation 2 Ruth Group, The (TRG)
Products Product Unyvero molecular diagnostics platform
  Product 2 Jefferies 2016 London Healthcare Conference
Index terms Index term Curetis–BIO (US): investor conference, 201610 supply service Curetis presents at BIO Investor Forum in San Francisco
  Index term 2 Curetis–Leucadia: investor conference, 201611 supply service Curetis attends Jefferies Global Healthcare Conference London
Persons Person Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland)
  Person 2 Roth, Lee (Ruth Group 201610)
     


Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced its participation in several major industry conferences in the fourth quarter of 2016. The respective presentations will be made available on the company’s website.


October:

Large & MidCap Event, October 5-6, 2016 - Paris, France: one-on-one meetings.

BIO Investor Forum, October 18-19, 2016 - San Francisco, CA, USA: company presentation and one-on-one meetings.

DKOU 2016 (German Congress of Orthopedics and Traumatology), October 25-28, 2016 - Berlin, Germany: scientific meeting. Exhibition booth Hall 2.2-71.
Joint symposium with Heraeus Medical, October 27, 2016, at 1:00 pm, room Berlin 2.


November:

SOFCOT 2016 (Congress of the French Society of Orthopedic Surgery & Traumatology), November 8-11, 2016 - Paris, France: scientific meeting. Exhibition booth no. 5952.

AMP 2016 (Association for Molecular Pathology), November 11-12, 2016 - Charlotte, NC, USA: scientific meeting. Exhibition booth no. T13C.

Jefferies 2016 London Healthcare Conference, November 16-17, 2016 – London, United Kingdom: one-on-one meetings.

Biotech and Money Inv€$tival Showcase, November 18, 2016 – London, United Kingdom: company presentation and one-on-one meetings.


###

About Curetis

Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques.

To date, Curetis has raised EUR 44.3 million in an IPO on Euronext Amsterdam and Euronext Brussels and private equity funds of over EUR 63.5 million. The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia.

For further information, please visit www.curetis.com.


Legal Disclaimer

This document constitutes neither an offer to buy nor to subscribe securities and neither this document nor any part of it should form the basis of any investment decision in Curetis.

The information contained in this press release has been carefully prepared. However, Curetis bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. Curetis does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.

This press release includes statements that are, or may be deemed to be, “forward-looking statements”. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes”, “estimates”, “anticipates”, “expects”, “intends”, “may”, “will”, or “should”, and include statements Curetis makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Curetis’ actual results may differ materially from those predicted by the forward-looking statements. Curetis undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.


Contact details

Curetis
Max-Eyth-Str. 42
71088 Holzgerlingen, Germany
Tel. +49 7031 49195-10
pr@curetis.com or ir@curetis.com
www.curetis.com - www.unyvero.com
International Media & Investor Inquiries

akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info@akampion.com
Tel. +49 40 88 16 59 64
Tel. +49 30 23 63 27 68

U.S. Media & Investor Inquiries
The Ruth Group
Lee Roth
lroth@theruthgroup.com
Tel. +1 646 536 7012

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Curetis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px